STOP BLEEDING IN SECONDS

Our mission is to save lives. We provide a safe, effective, and reliable solution to stop bleeding.

As seen in

As seen in

Technology

There is an extreme need to stop bleeding quickly and effectively with a product that is safe, easily used, and able to be used at the point of care.

Our Headquarters

122 18th St, Brooklyn,
NY 11215, US.

Our Product | VETIGEL®

VETIGEL® is a single-use, prescription hemostatic gel for veterinary use only. VETIGEL® helps control bleeding in animals by achieving hemostasis in seconds. For additional information, refer to Instructions for Use.

About Cresilon

Our plant-based technology has revolutionized the current standard of care by stopping traumatic and surgical bleeds in seconds without the need for manual pressure. Cresilon’s current and future product lines target veterinary, human trauma, and human surgical applications. 

Our Story

Constantly experimenting with natural materials in the lab as a young adult, Joe Landolina developed an adhesive hemostatic gel composed of plant-based polymers that could support the natural clotting process.

Our Management

Cresilon’s management has the right mix of passion and experience. 

Technology

Cresilon commercializes medical device technology in the animal health, trauma care, and surgical markets. Cresilon has created VETIGEL®, the first hemostatic gel for the veterinary market that stops bleeding in seconds.

Our Product | VETIGEL®

VETIGEL® can help control bleeds in animals by achieving hemostasis in seconds. For additional information, refer to Instructions for Use.

Stops Bleeding In Seconds

When applied to a wound, VETIGEL® controls bleeding on contact​

Plant-Based

All VETIGEL® proprietary polymers are derived from non-animal sources​

Biocompatible

VETIGEL® was subjected to applicable ISO 10993 testing and interpreted for veterinary use​

No Manual Pressure Needed

VETIGEL® creates a mechanical seal by applying its own pressure​

News

Cresilon Announces Distribution Partnerships for VETIGEL with Leading Animal Health and Veterinary Product Suppliers

NEW YORK (April 19, 2024) — Cresilon Inc. (“Cresilon”), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons through several of the leading animal health and veterinary product suppliers in the U.S., including Covetrus, MWI Animal Health, and Patterson Veterinary Supply.

This company’s hummus-colored gel could change how doctors stop bleeding

Cresilon’s hemostatic gel that can help blood clot without pressure has made it one of the most innovative medical device companies of 2024.

Every year, about 1.5 million people worldwide die from blood loss. The problem is especially acute when the loss is caused by trauma, which has no elegant solutions—you apply pressure and hope it stops. But Brooklyn-based Cresilon has developed a novel way to stanch bleeding: Cresilon Hemostatic Gel (CHG).

 

Cresilon Launches “VETIGEL Gives” to Sponsor Life-Saving Surgeries for Animals in Need

Company behind groundbreaking hemostatic technology launches animal philanthropy program at a time when nearly 30% of U.S. pet owners experience barriers to veterinary care

 

Subscribe to our Newsletter

Stay in touch with us to get Cresilon’s latest news, investment opportunities, and product releases. 

Floating Sticky Button

Address

122 18th St, Brooklyn, NY 11215 USA

Call Us

(347) 435-2226

Email Us

info@cresilon.com